SARAH LORD: Open Payments
NPI 1013569201 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,329 in 118 payments from 19 companies in 2025. Trend: 2023 $2,161 · 2024 $2,452 · 2025 $2,329
Food & beverage: $2,329
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 19 | $436 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $252 |
| Teva Pharmaceuticals USA, Inc. | 13 | $214 |
| Axsome Therapeutics, Inc. | 10 | $210 |
| Alkermes, Inc. | 13 | $206 |
| Corium, LLC | 5 | $142 |
| Janssen Pharmaceuticals, Inc | 5 | $136 |
| Lundbeck LLC | 7 | $133 |
| Otsuka America Pharmaceutical, Inc. | 6 | $125 |
| ABBVIE INC. | 5 | $103 |
Products named: INGREZZA, REXULTI, CAPLYTA, AUSTEDO XR, Auvelity, Azstarys, SPRAVATO, LYBALVI.
Industry payments across TN — which companies pay providers there.
